User Notice: The site will be occasionally unavailable due to scheduled maintenance this weekend. Please accept our apologies for any inconvenience.
Oncimmune Holdings Plc

Oncimmune (ONC)

Buy
Sell
Company name:Oncimmune Holdings Plc
EPIC:ONCTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00BYQ94H38
Market Segment:ASQ1Share Type:DE
WWW Address:Description:ORD 1P
Industry Sector:HEALTH CARE EQUIPMENT & SERVICES
 Price Price Change [%] Bid Offer Open High Low Volume
 236.00 images.advfn.com/imagesnew/2/gb/up 3.0 [1.29] 230.00 239.00 234.50 234.50 227.00 40,512
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 163.07 69.10 -0.01 -13.36 - - - 260.50 - 73.50

Oncimmune Key Figures

(at previous day's close)
Market Cap.163.07m
Shares In Issue69.10m
Prev. Close233.00
PE Ratio- 
Dividend Yield-%
EPS - basic-13.36p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-12.88p
Return On Equity (ROE)-%
Operating Margin-1,922.00%
PEG Factor- 
EPS Growth Rate-3.01%
Dividends PS Growth Rate-%
Net Debt6.27m
Gross Gearing101.88%
Quick Assets6.05m
Net Working Capital2.76m
Intangibles / Fixed Assets90.46%
Turnover PS0.74p
Pre-Tax Profit PS-14.16p
Retained Profit PS-12.12p
Cash PS6.14p
Net Cash PS1.12p
Net Tangible Asset Value PS *-5.63p
Net Asset Value PS-0.28p
Spread9.00 (3.77%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Oncimmune Balance Sheet

L^ONC:Liabilities+EQL^ONC:Assets

Share Price Performance

Sample Period †HighLow
1 week249.50219.50
4 weeks260.50203.00
12 weeks260.50171.50
1 year260.5073.50

Share Price Chart (5 years)

Oncimmune Historic Returns

Period †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week249.50-13.50-5.41219.500.07235.55
4 weeks233.003.001.29203.000.08235.23
12 weeks177.5058.5032.96171.500.20201.99
26 weeks172.5063.5036.81157.500.13192.97
1 year76.00160.00210.5373.500.15156.55
3 years127.50108.5085.1031.500.10117.52
5 years133.50102.5076.7831.500.08120.00
† periods calculated are whole weeks rather than calendar months

Oncimmune Key Management Ratios

Oncimmune Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 16.52 
Tobin's Q Ratio (excl. intangibles)25.01 
Dividend Yield-%
Market-to-Book Ratio-840.57 
Price-to-Pre-Tax Profit PS-16.67 
Price-to-Retained Profit PS-19.47 
Price-to-Cash Flow PS-18.32 
Price-to-Sales PS320.37 
Price-to-Net Tangible Asset Value PS-41.90 
Price-to-Cash PS38.46 
Net Working Capital PS3.99 
Price Pct to Working Capital PS59.08%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Oncimmune Financial Ratios

(Leverage Ratios)
Debt Ratio102.83%
Debt-to-Equity Ratio-36.30 
Debt-to-Equity Ratio (excl. Intgbl)-1.81 
Debt-to-Equity Market Value0.04 
Net Gearing60.78%
Net Gearing (excl. Intangibles)94.74%
Gross Gearing101.88%
Gross Gearing (excl. Intangibles)158.82%
Gearing Under 1 Year33.61%
Gearing Under 1 Year (excl. Intgbl)52.40%
Assets/Equity-53.17 
Cash/Equity-2,185.57 
(Liquidity Ratios)
Net Working Capital to Total Assets26.76%
Current Ratio1.80 
Quick Ratio (Acid Test)1.75 
Liquidity Ratio1.22 
Cash & Equiv/Current Assets68.09%
(Solvency Ratios)
Enterprise Value165.87m
CFO/Sales-17.49 
CFO/Attributable Profit- 
CFO/Assets-0.86 
CFO/Debt-0.85 
Total Debt/Equity Market Value0.06 
Total Debt/Sales20.65 
Total Debt/Pre-Tax Profit-1.07 
Total Debt10.51m
Total Debt/Net Current Assets3.81%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-10.71%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs3 
Beta (60-Mnth)Beta (36-Mnth)
-0.0140-0.0255

Oncimmune Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-142.86%
Return On Assets (ROA)-84.83%
Net Profit Margin-1,645.38%
Assets Turnover0.05 
Return On Equity (ROE)-%
Return On Investment (ROI)-110.06%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-1,645.38%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.13 
Fixed Assets Turnover0.14 
Current Assets Turnover0.08 
Net Working Capital Turnover 
Inventory Turnover2.18 
(Other Operating Ratios)
Total Assets-to-Sales19.40 
Debtors-to-Sales212.38%
Debt Collection Period775.18Days

Oncimmune Dividends

Sorry No Data Available

Oncimmune Fundamentals
 31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
turnover0.22-0.24-0.17-0.51-m
pre tax profit-5.32--6.34--8.55--9.78-m
attributable profit-4.80--6.37--8.03--8.38-m
retained profit-4.80--6.37--8.03--8.38-m
eps - basic (p)-9.84 -11.41 -12.97 -13.36 
eps - diluted (p)-9.84 -11.41 -12.97 -13.36 
dividends per share- - - - 

Oncimmune Balance Sheet

 31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
L^ONC:Liabilities+EQL^ONC:AssetsL^ONC:Liabilities+EQL^ONC:AssetsL^ONC:Liabilities+EQL^ONC:AssetsL^ONC:Liabilities+EQL^ONC:Assets
 31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
ASSETS
fixed assets fixed assets0.233.59%0.201.39%0.424.47%0.393.78%m
intangibles intangibles0.528.08%0.674.66%3.0131.92%3.7035.85%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.325.04%0.302.05%0.293.10%0.171.69%m
debtors debtors0.264.07%0.292.02%0.353.70%1.8117.58%m
cash & securities cash & securities5.0879.21%12.9589.88%5.3656.81%4.2441.11%m
TOTAL6.41100%14.41100%9.43100%10.32100%m
LIABILITIES
creditors - short creditors - short1.4021.90%0.855.89%1.0611.24%3.4733.61%m
creditors - long creditors - long--%--%0.515.37%7.0468.27%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL1.4021.90%0.855.89%1.5716.60%10.51101.88%m
EQUITY
ord cap, reserves ord cap, reserves5.0078.10%13.5694.11%7.8783.40%-0.19-1.88%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL5.0078.10%13.5694.11%7.8783.40%-0.19-1.88%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Oncimmune Cash Flow Statement

31 May 2017 (GBP)31 May 2018 (GBP)31 May 2019 (GBP)31 May 2020 (GBP)
Operating CF-4.28-6.10-7.36-8.90m
Pre-Financing CF-4.67-6.41-7.52-8.56m
Retained CF-5.097.88-7.60-1.12m

Oncimmune Brokers

Broker infomation is not available for this class of stock.
ADVFN Advertorial
Your Recent History
LSE
ONC
Oncimmune
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20210508 19:36:32